The purpose of the study is to determine if an oral ketone beverage is safe and well-tolerated during moderate intensity exercise in participants with long-chain fatty acid oxidation disorders and if it will raise blood ketones to levels similar to that reported among normal healthy subjects.
Purpose: Subjects with long-chain fatty acid oxidation disorders (LC-FAOD) do not make ketones during fasting or with exercise. Ketones are an important alternative energy substrate during moderate exercise, sparing the oxidation of glucose and providing a source of ATP to the central nervous system and exercising muscle. Fatty acid oxidation in the liver is required to make ketones. Subjects with a LC-FAOD cannot generate ketones because of their block in fatty acid oxidation during exercise. Providing ketones in an oral ketone beverage may increase blood ketones with exercise to levels normally observed in humans. Aim: To determine the safety and tolerability of an oral ketone beverage during moderate intensity exercise among subjects with a LC-FAOD compared to an isocaloric maltodextrin beverage, and to determine blood ketone concentrations. Hypothesis: Oral consumption of a ketone beverage before moderate intensity exercise will be safe and well-tolerated, and will raise blood ketones among subjects with a LC-FAOD to concentrations similar to that reported in the literature among normal healthy subjects.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Enrollment
5
Mix of sodium, calcium, and magnesium salts of D-beta-hydroxybutyrate with nicotinamide riboside chloride, flavors and stevia sweetener
Maltodextrin with flavors and stevia sweetener
Oregon Health & Science University
Portland, Oregon, United States
Adverse Events- incidence
Number of Adverse events
Time frame: 2 hours after product intake
Adverse Events- type
Description of Adverse events: categorical
Time frame: 2 hours after product intake
Adverse Events- severity
Severity of adverse event: grade 1-5
Time frame: 2 hours after product intake
Adverse Events- causal relationship
Yes/No related to product intake
Time frame: 2 hours after product intake
Abdominal discomfort
visual analogue scale (VAS) 0-10
Time frame: 2 hours after product intake
Decreased appetite
visual analogue scale (VAS) 0-10
Time frame: 2 hours after product intake
Gastric reflux
visual analogue scale (VAS) 0-10
Time frame: 2 hours after product intake
Nausea
visual analogue scale (VAS) 0-10
Time frame: 2 hours after product intake
Diarrhea
visual analogue scale (VAS) 0-10
Time frame: 2 hours after product intake
Headache
visual analogue scale (VAS) 0-10
Time frame: 2 hours after product intake
Blood Ketones
plasma beta-hydroxybutyrate concentration
Time frame: 20 minutes after moderate intensity exercise
Blood Creatine Kinase
plasma CK concentration
Time frame: 20 minutes after moderate intensity exercise
Blood Glucose
serum glucose
Time frame: 20 minutes after moderate intensity exercise
Blood Lactate
serum lactate concentration
Time frame: 20 minutes after moderate intensity exercise
Blood Pressure
diastolic BP
Time frame: peak 40 minute exercise
Blood Pressure
systolic BP
Time frame: peak 40 minute exercise
Perceived exertion
Borg scale 1-20
Time frame: peak 40 minute exercise
Respiratory Exchange Ratio
VCO2/VO2 0.7 - 1.0
Time frame: peak 40 minute exercise
Heart Rate
beats per minute
Time frame: peak 40 minute exercise
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.